Golden State IRB
California consortium aiming to create centralized IRB for clinical trials
The Partnership to Accelerate Clinical Trials is trying to eliminate the duplication of administration and regulation that can delay multicenter clinical trials by creating a centralized institutional review board and master clinical trial agreement recognized by research institutions across California.
The aim is to have at least five clinical trial sites across the state accept a common IRB and master clinical trial agreement by 2Q14 and have at least five clinical trials managed through the consortium's system by the end of next year.
The Partnership to Accelerate Clinical Trials (PACT) is the first project to come out of the Bay Area BioEconomy Initiative, which officially debuted this month with the goal of growing the San Francisco Bay Area bioeconomy.
Operators of clinical trial sites across the U.S. already can form their own IRB or designate an existing